Your browser doesn't support javascript.
loading
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma.
Huang, Jennifer; Phillips, Sharon; Byrne, Michael; Chinratanalab, Wichai; Engelhardt, Brian G; Goodman, Stacey A; Harrell, Shelton L; Jagasia, Madan; Kassim, Adetola; Rawling, Kyle T; Savani, Bipin N; Sengsayadeth, Salyka; Cornell, R Frank.
Affiliation
  • Huang J; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Phillips S; Division of Biostatistics and Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Byrne M; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Chinratanalab W; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Engelhardt BG; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Goodman SA; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Harrell SL; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Jagasia M; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Kassim A; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Rawling KT; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Savani BN; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Sengsayadeth S; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Cornell RF; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA. robert.f.cornell@vanderbilt.edu.
Bone Marrow Transplant ; 53(6): 701-707, 2018 06.
Article de En | MEDLINE | ID: mdl-29703965
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transplantation autologue / Transplantation de cellules souches hématopoïétiques / Conditionnement pour greffe / Bortézomib / Lénalidomide / Myélome multiple / Antinéoplasiques Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Bone Marrow Transplant Sujet du journal: TRANSPLANTE Année: 2018 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transplantation autologue / Transplantation de cellules souches hématopoïétiques / Conditionnement pour greffe / Bortézomib / Lénalidomide / Myélome multiple / Antinéoplasiques Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Bone Marrow Transplant Sujet du journal: TRANSPLANTE Année: 2018 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni